Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.49 |
| ▸ | FABP7 | O15540 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7037298 | 1.00 | KMT2A (0.54) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL30341743 | 0.88 | KMT2A (0.49) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL768971 | 0.87 | KMT2A (0.52) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL29823827 | 0.86 | KMT2A (0.50) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL7391410 | 0.85 | KMT2A (0.49) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL7389338 | 0.85 | KMT2A (0.49) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL7393490 | 0.85 | KMT2A (0.49) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL8236718 | 0.84 | KMT2A (0.51) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL28758363 | 0.84 | KMT2A (0.54) | KMT2AEPHX2FABP5FABP7CA1 | |
| SCHEMBL20623130 | 0.84 | KMT2A (0.50) | KMT2AEPHX2FABP5FABP7CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779646-B2 | Dynamic user-programmable materials including stimuli-responsive proteins | UNIVERSITY OF WASHINGTON (US) | 2023-10-10 | — | — | US | disclosed |
| US-20160137689-A1 | PEPTIDE-RESIN CONJUGATE AND USE THEREOF | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779646-B2 | Dynamic user-programmable materials including stimuli-responsive proteins | MSN, SUMO2, PEBP1 | KMT2A 1779/4885EPHX2 3723/4885FABP5 407/4885 |
| US-20160137689-A1 | PEPTIDE-RESIN CONJUGATE AND USE THEREOF | ARGLU1, ARG1, NPR1 | KMT2A 1856/4885EPHX2 460/4885FABP5 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.